{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6_0vcIDA","lastupdate":"2024-05-29T00:00:00.000Z","update_date":"2024-05-29T00:00:00.000Z","lastModified":"Feb 4, 2025","active":1,"confidence_score":98,"confidence_score_reason":"markets","urlname":"accellta","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$Aqqp8gSrS6W26bVIMes7LT6zIkn0vyfv4BDjudhq1gATbiJT6vtMJ5","name":"Accellta","oneliner":"Industrial-Scale Stem Cell Culturing for Research and Medicine","registrar":"514840446","website":"https://accellta.com","careerspage":"","founded_month":11,"founded_year":2012,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/10379250","instagram":""},"social":["https://www.linkedin.com/company/10379250"],"flattenedsociallinks":"https://www.linkedin.com/company/10379250","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":17,"patent":1,"raised":500000,"stage":"Mature","public_stage":"Mature","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Accellta specializes in large-scale production of embryonic and induced pluripotent stem cells, progenitors, and differentiated cells. These products are used in cell banking, drug discovery, regenerative medicine, and scientific research.\n\nThe company uses 3D carrier-free suspension systems under feeder-free, adherent-free, and xeno-free conditions, optimizing production efficiency and reducing costs while maintaining consistent quality.\n\nAccellta's manufacturing facility adheres to Good Manufacturing Practice (GMP) guidelines, supporting industrial-scale cell banking and clinical batch production. The company’s patent portfolio covers media formulations and pluripotent stem cell culturing techniques, reflecting its focus on advancing cell culture technologies.","climatetech_description":null,"is_climatetech_relevant":0,"phone":"0549885551|+972 54 9885551","country":null,"address":{"israeli":[{"id":"aacbba7b-3900-4cac-afc0-f2cc587f69f5","city":"Haifa","type":null,"address":"Haifa, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"North District","news":[{"id":"8236bf9c-985c-436c-a8a7-04e99d3900b9","date":"Mar 13, 2018","link":"http://www.globes.co.il/en/article-hitachi-chemical-licenses-stem-cell-technology-from-israels-accellta-1001227483","source":"www.globes.co.il","visible":1,"analysis":{"tags":"stem cell culture","company":"Accellta","layoffs":null,"summary":"Japanese company Hitachi Chemical has signed a Technical License Agreement with Accellta, a Haifa-based company that develops culture media and methods for stem cell production. Accelltas technologies aim to accelerate the use of stem cells for clinical and regenerative applications. The company has received investments from AMIT and Horizon Ventures. Hitachi Chemical, which recently acquired a US-based company in the regenerative medicine market, will utilize Accelltas stem cell culture media and methods to strengthen its technological capabilities in contracted cell manufacturing. Accellta also has agreements with Thermo Fisher and other companies and is considering a merger or IPO in the future.","partners":"Thermo Fisher","customers":null,"investors":"AMIT, Horizon Ventures","confidence":8,"key_topics":["Stem cells","Culture media","Regenerative medicine","Hitachi Chemical","Technological strength"],"date_of_event":"March 13, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$4 million","structured_issues":["Partners","Investment","Acquisition","Public Trading"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment  #Acquisition  #Public Trading","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Ii2ngc0nDN0kihNIWdntb1l1tNsJ2iILR0wQGDWZipclK7jwKx0rDB","news_summary":"Hitachi Chemical licenses stem cell tech from Israel's Accellta","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"44012efe-5d04-41f9-9d75-94198c576546","date":"Jul 13, 2017","link":"https://knect365.com/partnering-insight/article/0bbf31a6-bc6d-4246-a78e-0a2381f60868/accellta-ceo-says-israeli-stem-cell-specialist-seeks-global-partners","source":"knect365.com","visible":1,"analysis":{"tags":"stem cell culturing","company":"Accellta","layoffs":null,"summary":"Accellta CEO Itzchak Angel discusses the companys stem cell culturing process and future expansion plans, including a planned USD 15 million capital-raising exercise and the search for corporate partners. The potential applications of Accelltas technologies include cell-based medical therapies, research tools, drug screening and development, and tissue engineering.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["stem cell culturing","expansion plans","capital-raising exercise","search for corporate partners","potential applications"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$15 million","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"3ruLIWwDklSspGsSzVbVWYen4T5Pby7ivKMl3xUn3o8bmbZPbGVjoz","news_summary":"Accellta CEO says israeli stem cell specialist seeks global partners","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"be7c6709-c90f-4dce-bcb5-734a926b9eed","date":"May 25, 2016","link":"https://www.prnewswire.com/news-releases/nano-dimension-and-accellta-joined-forces-to-successfully-bioprint-stem-cell-derived-tissues-300274572.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":["3D printing","bioprinting","stem cells","collaboration","technology"],"company":"Nano Dimension Ltd.","layoffs":null,"summary":"Nano Dimension has successfully lab-tested a proof of concept 3D Bioprinter for stem cells in collaboration with Accellta Ltd. The trial confirmed that the companies technologies enabled printing of viable stem cells using an adapted 3D printer. The companies are considering the formation of a new entity for future solutions. The market for 3D bioprinting is expected to grow rapidly, and Nano Dimensions advanced inkjet technology may pave the way for advanced multi-material printing domains. Nano Dimension focuses on the development of advanced 3D printed electronics systems and nanomaterials. Accellta specializes in innovative media and technologies for culturing and differentiating human stem cells.","partners":["Accellta Ltd."],"customers":null,"investors":null,"confidence":8,"key_topics":["3D printing","bioprinting","stem cells","collaboration","technology"],"date_of_event":"May 25, 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"NAlDTLqSALyU4R6KLb2uSfcCAaRNv3GmHHypXfwof7P8Nqa6KIC2aW","news_summary":"Nano Dimension and Accellta Joined Forces to Successfully BioPrint Stem Cell-Derived Tissues","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"9ea6aa01-a822-4684-ad38-3a6388c3bc1f","date":"Apr 19, 2016","link":"https://globenewswire.com/news-release/2016/04/19/830348/0/en/Cellect-Announces-the-Signing-of-a-Collaboration-Agreement-with-Accellta.html","source":"globenewswire.com","visible":1,"analysis":{"tags":"collaboration agreement","company":"Cellect Biomed","layoffs":null,"summary":"Cellect Biomed has signed a collaboration agreement with Accellta, a leading Israeli stem cell company. Accellta will have a nonexclusive right to evaluate the impact of Cellects apoptotic induction based technology on its stem cell culturing technologies. The collaboration aims to grow Accelltas pluripotent cells safely and in a shorter time using Cellects technology. The potential market for these applications is estimated at billions of dollars. Accellta will pay Cellect approximately NIS300,000 for the limited right to test the technology. The evaluation stage will last several months, and if successful, the companies will negotiate the terms of a full license. Cellects business model focuses on developing its own products for medical applications and granting licenses for its technology to other companies and research institutions in the stem cell field.","partners":["Accellta"],"customers":null,"investors":null,"confidence":8,"key_topics":["stem cells","technology","feasibility tests","licensing agreement","tissue regeneration"],"date_of_event":"April 19, 2016","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"fp6bTOMz4vaSRsKXYSvKU1gsHjE17Ag6KgNFqe2ymdS1U1a1lzmkXz","news_summary":"Cellect Announces the Signing of a Collaboration Agreement with Accellta","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"9eb31a57-5728-4db4-ac43-7a3747bfd7a5","date":"Jun 8, 2015","link":"https://www.prnewswire.com/news-releases/accellta-grants-rights-for-its-feeder-free-stem-cell-culture-medium-to-thermo-fisher-scientific-506461341.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Partnership, Expansion","company":"Accellta","layoffs":"Not mentioned","summary":"Stem cell company Accellta has granted worldwide non-exclusive rights to Thermo Fisher Scientific for the manufacture and distribution of its proprietary cell culture medium and ancillary products and methods. Accelltas patented technology is designed to enable homogeneous growth of stem cell production by enabling culturing of the cells in feeder-free, serum-free and xeno-free media. The company is currently focused on creating strategic partnerships with biopharma and stem cell companies for developing large-scale and cost-effective tailor-made manufacturing processes for cell products.","partners":"Thermo Fisher Scientific","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":["Stem Cell","Partnership","Technology Licensing","Cell Culture Medium","Expansion"],"date_of_event":"June 8, 2015","valuation_amount":"Not mentioned","impact_on_company":"Growth-Positive","investment_amount":"Not mentioned","structured_issues":["Partners","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"F0lypf4CTa6pQ9h1xBKsJj1c8sKA4eBY6PhRjV8gumqyD7OY2CZudz","news_summary":"Accellta Grants Rights for its Feeder-free Stem Cell Culture Medium to Thermo Fisher Scientific","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d9b5d43d-83ee-4011-9739-cef7224b6600","date":"Apr 14, 2015","link":"http://www.globes.co.il/en/article-accelta-signs-strategic-agreement-with-stemcell-technologies-1001028420","source":"www.globes.co.il","visible":1,"analysis":{"tags":"stem cells","company":"Accelta","layoffs":null,"summary":"Israeli stem cell company Accelta has signed an exclusive agreement with Stemcell Technologies to market its culturing solution for growing stem cells. Accelta has completed a seed round with participation from AMIT, Horizon Ventures, and Rambam Hospital. The companys products allow for the growth of stem cells without using feeders, animal products, or adhesive surfaces, which significantly lowers the cost. The partnership with Stemcell Technologies is expected to maximize the global accessibility of Acceltas solutions.","partners":["Stemcell Technologies"],"customers":null,"investors":["AMIT","Horizon Ventures","Rambam Hospital"],"confidence":9,"key_topics":["Accelta","Stemcell Technologies","seed round","stem cells","partnership"],"date_of_event":"April 14, 2015","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"x5B92V1pnGaVA0dENjG358ikJrLfyA5Ytq0FVIaW0Z7tMZbYTOqLDo","news_summary":"Accelta signs collaboration with Stemcell Technologies","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"bf675445-ad0b-4a23-8411-89717cf488aa","date":"Jul 1, 2014","link":"http://www.businesswire.com/news/home/20140701005819/en/Licensing-Deals-Stem-Cell-Company-Accellta#.VKvPMHuMmwg","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"agVVfJ73CSCnzMQb3zEPDkMj3qAoQ7sbJ1HEt9radCxAhtqw5F1bWa","news_summary":"First Licensing Deals for Stem Cell Company Accellta","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":7,"techcommunityinvolvement":null,"mediagallery":[{"id":"anbqfofiHBtHD9a02cO6RY8GmAyrFH5SreDmURzRPWJRutUIRQ5zua","timestamp":"2024-07-03 14:36:11.000000","resources_type":1,"resources_title":"Cultured Milk Fat (AMF)","resources_file_name":"$e8NHwYf2pIdnKu7fK0nG4sJo9EZ4y9ntMUg8ccnJsawopMrxshzNxM.png","alt":"Cultured Milk Fat (AMF) logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$e8NHwYf2pIdnKu7fK0nG4sJo9EZ4y9ntMUg8ccnJsawopMrxshzNxM.png","url":"https://storage.googleapis.com/clean-finder-353810/$e8NHwYf2pIdnKu7fK0nG4sJo9EZ4y9ntMUg8ccnJsawopMrxshzNxM.png"},{"id":"5aa22220-eeaa-48bf-b0fd-9df9421e4d54","timestamp":"2019-08-06 08:04:24.000000","resources_type":1,"resources_title":"","resources_file_name":"$jacdt41Pwrb2WKuQIyFYlhbZd5p5K3lKZPhkuEEHQXrd2k7hE1V3JO","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$jacdt41Pwrb2WKuQIyFYlhbZd5p5K3lKZPhkuEEHQXrd2k7hE1V3JO","url":"https://storage.googleapis.com/clean-finder-353810/$jacdt41Pwrb2WKuQIyFYlhbZd5p5K3lKZPhkuEEHQXrd2k7hE1V3JO"},{"id":"f13721e1-4366-46bd-86f0-b61fe76711fd","timestamp":"2019-08-06 08:01:53.000000","resources_type":1,"resources_title":"","resources_file_name":"$iCC9ERvTtc2LBAweU5cqaExIgbrxjfd6MgTGnvBhMIFU44UcOVMsFY","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$iCC9ERvTtc2LBAweU5cqaExIgbrxjfd6MgTGnvBhMIFU44UcOVMsFY","url":"https://storage.googleapis.com/clean-finder-353810/$iCC9ERvTtc2LBAweU5cqaExIgbrxjfd6MgTGnvBhMIFU44UcOVMsFY"}],"tags":["foodtech","regenerative-medicine","biotechnology","medical-technologies","stem-cells","bioprocess","laboratories","3d-technology","drug-discovery","pharma-companies","healthcare-providers","food-and-beverage","manufacturing-facilities","clinics"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Oek-_oKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Nvx3J0KDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":[{"date":"2012-11-01","name":"Scale-up and low cost of stem cell culturing","tags":["stem-cells","bioprocess","medical-technologies","biotechnology"],"category":"Life Sciences & Biotechnology","tto_logo":"/image_cloud/t3_tto_logo_f5fde2b3-6016-11e8-abf1-41fdcbb0dda6","university_logo":"/image_cloud/t3_institution_logo_f5fde2b3-6016-11e8-abf1-41fdcbb0dda6"}],"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":[],"geomarkets":["Global","Europe","Americas","Asia"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":2,"lastfunding":"$500K","totalrounds":3,"fundingstage":"Mature","totalfunding":"$500K","publicinvestors":2,"lastpublicfunding":500000,"totalpublicrounds":3,"totalpublicfunding":500000},"team":[{"name":"Michal Amit","email":"yearitr@accellta.com","phone":"0526081155","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4N2o7osKDA","bounced":false,"claimed":1,"founder":0,"urlname":"michal-amit","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg_fqEgwoM","position":"CEO & CTO","last_name":"Amit","claimtoken":"2cc3f1f108b59a0356545256ef65cfff6570bba5e6485506748555b687225db5","first_name":"Michal","picturekey":"$oeDxYLN2qtkzk8jDnz2p3TeJ3B1IozCp1ZlyhSlXhYZcS8pJYCudkp.jpeg","claimeddate":"2020-12-07","linkedinurl":"https://www.linkedin.com/in/michal-amit-92823114b/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-12-07 09:55:17.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$oeDxYLN2qtkzk8jDnz2p3TeJ3B1IozCp1ZlyhSlXhYZcS8pJYCudkp.jpeg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Yael Garfinkel","email":"","phone":"","gender":"Female","userid":"7cUcyLupVAQGhqeYAnyDvakbKPSaBMzGVQKoYjDwCQR4oywXhSrOTh","bounced":false,"claimed":null,"founder":0,"urlname":"yael-garfinkel","visible":1,"memberid":"sJbTEmX1PAj3nmHYF8LEzPnAPMwJWgkxKRuYVXvSAi9xwmXSLCy0Sa","position":"Chief Financial Officer","last_name":"Garfinkel","claimtoken":null,"first_name":"Yael","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yael-garfinkel/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"YG","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Aviram Amit","email":"aviram@accellta.com","phone":"0549885551","gender":"Male","userid":"borPiZ23k5LxNaJhAkzgt8VkXCwhBLfmwGyJTuC2VGQK20Ap7YLCgc","bounced":false,"claimed":null,"founder":0,"urlname":"aviram-amit-2","visible":1,"memberid":"gfE4nzCpXZzjpeU8e3EEq9oO0VmhgXMRtYARpm9iVefSoPO7Gp6SBh","position":"Business Development Manager","last_name":"Amit","claimtoken":"3rhcA5kzl9RmNmkWsdkoWvqHxjpOR2T2fRyNYOkRRSAbKDcwR3DRzO","first_name":"Aviram","picturekey":"$NPyy0FeDL8vJE9AjrsjKFBkw2RUJKqKB49SydmvlRIPZQSPGeodM5x.jpeg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/aviram-amit/","unsubscribed":false,"is_activeuser":1,"additionalemail":"aviram@accellta.com","claimedemaildate":"2024-05-29 15:16:51.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$NPyy0FeDL8vJE9AjrsjKFBkw2RUJKqKB49SydmvlRIPZQSPGeodM5x.jpeg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"shahar Ben Shaul","email":"shahar@accellta.com","phone":"","gender":"Female","userid":"qdUNMuu30C1HI5LBcnSnjl2RhjaPbWjYa48uRn9Ts6jXmGXXOaKXvq","bounced":false,"claimed":null,"founder":0,"urlname":"shahar-ben-shaul-2","visible":1,"memberid":"9n56cBeliPel07h6NKS1Q7CGWl4iP0hSX83zifC7whQliFtBWZZG62","position":"R&D Manager","last_name":"Ben Shaul","claimtoken":"jZSImE90NBUv39rzs6SyBjwEWGiC0oyV2s3ozIovMzfvEBOg12Vcz7","first_name":"shahar","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shahar-ben-shaul-9a6626175/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-05-29 15:17:26.000000","initials":"SB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN7UwIEIDA","fullname":"Aviv Alper"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-03-03T00:00:00.000Z","crunchbaseid":"accellta","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":null,"creator_email":null,"createdate":"2015-01-06T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Aviv Alper","affiliatedOrganizations":null,"timeline":[{"id":"h8yk2nH7r96doSqrvhUtwHtBdP92qL7xCPHQe2e4LaoO3uXGWv6v1p","date":"Jan 2024","amount":"$500K","source":"https://www.linkedin.com/posts/accellta-ltd%2E_dairyinnovation-cultivatedmilkfat-altdairy-activity-7143180969959751681-59_n?utm_source=share&utm_medium=member_desktop","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority ","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/israel-innovation-authority-1","logokey":"$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","tagline":"Governmental grant for POC ","urlname":"/investor_page/israel-innovation-authority-1","isisraeli":1,"investorid":"8TrglTPuxDd2ABfwzfoRPSHOLbGlGXhvTxe0CF3zKPbddG3xPprg1h","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"MLgB3MJjLEhiT1wyZrfb7gNxKXA5o1Qj1kICDGvDyqqWE0Og0jkwN8","fundingsubtype":"Grant Provider","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD426HBCAw","date":"Nov 2014","amount":"Undisclosed","source":"From the founder","eventtype":"FundingRoundEvent","investment":[{"name":"AMIT-Technion ( The Alfred Mann Institute)","type":"Company","amount":0,"hidden":true,"country":"Israel","fullurl":"/company_page/amit-technion-the-alfred-mann-institute","logokey":"$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","tagline":"Development & Commercialization of Biomedical Innovations Conceived by Technion Researcher","urlname":"/company_page/amit-technion-the-alfred-mann-institute","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODUpcX1Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"d736263e-26d8-4a00-bcd3-6f258658bac1","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","leadcaption":"","followupcaption":"Follow on "},{"name":"Horizons Ventures","type":"Investor","amount":0,"hidden":false,"country":"Hong Kong","fullurl":"/investor_page/horizons-ventures","logokey":"$aZVfKKZS0BHpFQbpvQsQ66Z7F7I2NrJOvFivKxCWJAK2Y7d3WhHkFR","tagline":null,"urlname":"/investor_page/horizons-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4MPh7psLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d76f84a5-42a0-4647-a366-89af288b911e","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$aZVfKKZS0BHpFQbpvQsQ66Z7F7I2NrJOvFivKxCWJAK2Y7d3WhHkFR","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk8NCNCww","date":"Nov 2012","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"AMIT-Technion ( The Alfred Mann Institute)","type":"Company","amount":0,"hidden":true,"country":"Israel","fullurl":"/company_page/amit-technion-the-alfred-mann-institute","logokey":"$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","tagline":"Development & Commercialization of Biomedical Innovations Conceived by Technion Researcher","urlname":"/company_page/amit-technion-the-alfred-mann-institute","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODUpcX1Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"416acbd8-115e-47b6-bef1-3c485d65a5b0","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"11/2012","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Accellta","logourl":"https://storage.googleapis.com/clean-finder-353810/$Aqqp8gSrS6W26bVIMes7LT6zIkn0vyfv4BDjudhq1gATbiJT6vtMJ5","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$Aqqp8gSrS6W26bVIMes7LT6zIkn0vyfv4BDjudhq1gATbiJT6vtMJ5","seoabout":"Accellta specializes in large-scale production of embryonic and induced pluripotent stem cells, progenitors, and differentiated cells. These products are u...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":4,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Cells","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Agriculture & Food","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Processed Foods","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Beverages","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwKDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Laboratories","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","classificationName":"targetcustomer"},{"depth":1,"name":"Industrial Manufacturing","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Manufacturing Facilities","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Oek-_oKDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA>Processed Foods#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA>Beverages#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA>Processed Foods#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Cells#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA>Manufacturing Facilities#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Oek-_oKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Laboratories#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA|2:>IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA/Processed Foods#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA|3:>IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA>Processed Foods#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA/Beverages#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwKDA|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Laboratories#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA|1:>IndustryClassificationModel/Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA|2:>IndustryClassificationModel>Industrial Manufacturing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA/Manufacturing Facilities#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Oek-_oKDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Cells#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Agriculture & Food","key":"0-0","path":"IndustryClassificationModel>Agriculture & Food","children":[{"title":"Processed Foods","key":"0-0-0","path":"IndustryClassificationModel>Agriculture & Food>Processed Foods","children":[{"title":"Beverages","key":"0-0-0-0","path":"IndustryClassificationModel>Agriculture & Food>Processed Foods>Beverages"}]}]},{"title":"Healthcare & Life Sciences","key":"0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-1-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"},{"title":"Biotechnology","key":"0-1-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Biotechnology"}]},{"title":"Healthcare","key":"0-1-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-1-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"},{"title":"Laboratories","key":"0-1-1-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Laboratories"}]}]},{"title":"Industrial Manufacturing","key":"0-2","path":"IndustryClassificationModel>Industrial Manufacturing","children":[{"title":"Manufacturing Facilities","key":"0-2-0","path":"IndustryClassificationModel>Industrial Manufacturing>Manufacturing Facilities"}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Cells","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Cells"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Cells","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7vMIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Agriculture & Food","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Processed Foods","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Beverages","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwKDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Laboratories","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","classificationName":"targetcustomer"},{"depth":1,"name":"Industrial Manufacturing","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom_sKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Manufacturing Facilities","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Oek-_oKDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Biologicals","Cells"],"targetCustomer":["Agriculture & Food","Processed Foods","Beverages","Healthcare & Life Sciences","Life Sciences","Pharmaceuticals","Biotechnology","Healthcare","Providers","Laboratories","Industrial Manufacturing","Manufacturing Facilities"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD426HBCAw","date":"Nov 2014","amount":"Undisclosed","source":"From the founder","eventtype":"FundingRoundEvent","investment":[{"name":"AMIT-Technion ( The Alfred Mann Institute)","type":"Company","amount":0,"hidden":true,"country":"Israel","fullurl":"/company_page/amit-technion-the-alfred-mann-institute","logokey":"$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","tagline":"Development & Commercialization of Biomedical Innovations Conceived by Technion Researcher","urlname":"/company_page/amit-technion-the-alfred-mann-institute","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODUpcX1Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"d736263e-26d8-4a00-bcd3-6f258658bac1","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","leadcaption":"","followupcaption":"Follow on "},{"name":"Horizons Ventures","type":"Investor","amount":0,"hidden":false,"country":"Hong Kong","fullurl":"/investor_page/horizons-ventures","logokey":"$aZVfKKZS0BHpFQbpvQsQ66Z7F7I2NrJOvFivKxCWJAK2Y7d3WhHkFR","tagline":null,"urlname":"/investor_page/horizons-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4MPh7psLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d76f84a5-42a0-4647-a366-89af288b911e","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$aZVfKKZS0BHpFQbpvQsQ66Z7F7I2NrJOvFivKxCWJAK2Y7d3WhHkFR","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk8NCNCww","date":"Nov 2012","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"AMIT-Technion ( The Alfred Mann Institute)","type":"Company","amount":0,"hidden":true,"country":"Israel","fullurl":"/company_page/amit-technion-the-alfred-mann-institute","logokey":"$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","tagline":"Development & Commercialization of Biomedical Innovations Conceived by Technion Researcher","urlname":"/company_page/amit-technion-the-alfred-mann-institute","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODUpcX1Cgw","fundingtype":"Company","leadpartner":null,"investmentid":"416acbd8-115e-47b6-bef1-3c485d65a5b0","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xaIv6yseodBT8RCm5EBa6KRdWSlNBvAp6GU5tcYr8byE9pBjAKeSIT","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"h8yk2nH7r96doSqrvhUtwHtBdP92qL7xCPHQe2e4LaoO3uXGWv6v1p","date":"Jan 2024","amount":"$500K","source":"https://www.linkedin.com/posts/accellta-ltd%2E_dairyinnovation-cultivatedmilkfat-altdairy-activity-7143180969959751681-59_n?utm_source=share&utm_medium=member_desktop","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority ","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/israel-innovation-authority-1","logokey":"$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","tagline":"Governmental grant for POC ","urlname":"/investor_page/israel-innovation-authority-1","isisraeli":1,"investorid":"8TrglTPuxDd2ABfwzfoRPSHOLbGlGXhvTxe0CF3zKPbddG3xPprg1h","fundingtype":"Grant Provider","leadpartner":null,"investmentid":"MLgB3MJjLEhiT1wyZrfb7gNxKXA5o1Qj1kICDGvDyqqWE0Og0jkwN8","fundingsubtype":"Grant Provider","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3Fnyw6sWSY0hZOuxYHCPlbAw21MX276wA1ASUaacUlwfZPModDvmko","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}